Contractors › LEIDOS BIOMEDICAL RESEARCH INC
LEIDOS BIOMEDICAL RESEARCH INC: federal contracts
$1.3Bobligated, last 24 months
41contract actions
$826.0Mlargest single action
17contracts ending within 18 months
| UEI | HV8BH9BPG8Y9 |
|---|---|
| CAGE code | 8HTA1 |
| Location | FREDERICK, MD, USA |
| SAM registration | Active when retrieved (05 October 2026); expires 26 January 2027 |
| SBA certifications | None on record |
| In business since | 27 June 2000 |
Registration details from SAM.gov, retrieved 05 October 2026. Award figures from USASpending.gov (task orders and definitive contracts; IDIQ ceilings excluded), updated nightly. Last award action: 29 September 2026.
Agencies they work for
| Buyer | Obligations, 3 yrs | Contracts |
|---|---|---|
| National Institutes of Health (NIH) | $1.8B | 61 |
Industries (NAICS)
| NAICS | Industry | Obligations, 24 mo | Awards |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $1.3B | 41 |
What they deliver (product and service codes)
| PSC | Description | Obligations, 36 mo | Awards |
|---|---|---|---|
| AN12 | Health R&D Services; Health Care Services; Applied Research | $1.8B | 61 |
Contracts expiring in the next 18 months
17 contracts worth $1.6B.
| Incumbent | Buyer | What | Value | Ends | Est. solicitation | Record |
|---|---|---|---|---|---|---|
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $79.9M | 31 October 2026 | Now / imminent | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $813K | 24 November 2026 | Now / imminent | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $8.0M | 31 December 2026 | Now / imminent | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $33.3M (4 orders) | 31 January 2027 | Now / imminent | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $183.5M (5 orders) | 28 February 2027 | Now / imminent | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $14.0M (2 orders) | 31 March 2027 | Now / imminent | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $1.1M | 27 April 2027 | ~Q4 2026 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $58.4M (2 orders) | 25 May 2027 | ~Q4 2026 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $11.8M | 24 June 2027 | ~Q4 2026 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $16.9M | 26 July 2027 | ~Q1 2027 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $969.3M (4 orders) | 30 August 2027 | ~Q1 2027 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $107.4M (15 orders) | 30 September 2027 | ~Q2 2027 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $478K | 07 October 2027 | ~Q2 2027 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $58.9M (4 orders) | 31 December 2027 | ~Q3 2027 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $2.0M (2 orders) | 19 January 2028 | ~Q3 2027 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $102.0M (3 orders) | 29 February 2028 | ~Q3 2027 | USASpending |
| LEIDOS BIOMEDICAL RESEARCH INC | NIH | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) | $2.0M | 03 March 2028 | ~Q3 2027 | USASpending |
Contracts and task orders from USASpending.gov (FPDS) whose period of performance ends within 18 months, valued at $25K or more, excluding IDIQ ceilings and government-owned, contractor-operated facility contracts. Co-terminous orders from the same vendor, agency, NAICS and PSC ending in the same month are grouped. The solicitation date is an estimate (about six months before the contract ends): FedSift does not know whether a follow-on has been posted, so check SAM.gov.
Verify on SAM.gov: exclusions search (public). The SAM.gov entity record itself requires a SAM.gov sign-in.
Considering LEIDOS BIOMEDICAL RESEARCH INC as a teaming partner?
FedSift's Partner Finder shows their certifications, registration status and exclusions in one dossier, and ranks alternatives for the role you need. Free plan available, no credit card.